| (210) | Number of the EPO application | 21173901 |
| (220) | Filing date of the EPO application | 2017.02.01 |
| (80) | EPO patent specification publication (B) | EPB nr. 15/2024, 2024.04.10 |
| (110) | EPO patent number | 3925956 |
| (21) | Number of the application | e 2022 0889 |
| (71) | Name(s) of applicant(s), code of the country | BioCryst Pharmaceuticals, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | KOTIAN Pravin L, US;
BABU Yarlagadda S., US;
ZHANG Weihe, US;
VOGETI Lakshminarayana, US;
WU Minwan, US;
CHINTAREDDY Venkat R., US;
RAMAN Krishnan, US; |
| (73) | Name(s) of owner(s), code of the country | BioCryst Pharmaceuticals, Inc., US; |
| (54) | Title of the invention | 1H-INDAZOLE-3-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS FACTOR D INHIBITORS FOR TREATING DISEASES CHARACTERIZED BY ABERRANT COMPLEMENT SYSTEM ACTIVITY, SUCH AS E.G. IMMUNOLOGICAL DISORDERS |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07D 401/12 (2006.01.01); C07D 231/56 (2006.01.01); C07D 209/40 (2006.01.01); C07D 209/48 (2006.01.01); C07D 487/04 (2006.01.01); C07D 471/04 (2006.01.01); C07D 403/12 (2006.01.01); C07D 403/04 (2006.01.01); C07D 403/06 (2006.01.01); C07D 401/14 (2006.01.01); C07D 401/04 (2006.01.01); C07D 401/06 (2006.01.01); C07D 405/12 (2006.01.01); C07D 209/12 (2006.01.01); C07D 209/42 (2006.01.01); A61K 31/416 (2006.01.01); A61P 37/00 (2006.01.01); A61P 37/06 (2006.01.01); A61P 25/00 (2006.01.01); A61P 21/04 (2006.01.01); A61K 31/4439 (2006.01.01); A61K 31/404 (2006.01.01); A61P 13/00 (2006.01.01); A61K 31/4035 (2006.01.01); A61P 13/12 (2006.01.01); A61P 25/28 (2006.01.01); A61P 9/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2022.08.31 |
| (30) | Priority | 201662289653 P, 2016.02.01, US |